Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study

Li Zang(First Affiliated Hospital of Xinxiang Medical University), Yiming Mu(Chinese PLA General Hospital), HU Da-qing(Wuhan University), Nailong Yang(Qingdao University), Quanmin Li(Chinese PLA General Hospital), Mingming Liu(Anhui Medical University), Hui Jin(Zhongda Hospital Southeast University), Lixian Chen(Indiana University – Purdue University Indianapolis), Xiaoyun Shi(Nanchang University), Hong Fan(Sichuan University), Han Yin(University of California, San Francisco), Linlang Liang(General Hospital of Shenyang Military Region)
Diabetes Therapy
June 20, 2019
Cited by 4


Related Papers